Precision Medicine Market
Precision Medicine Industry Analysis Report 2024 - Global Market Revenue to Reach $168.3 Billion by 2032, Challenged by High Costs, Complex Regulatory Environments, and the Need for Extensive Data Integration
October 10, 2024 04:24 ET | Research and Markets
Dublin, Oct. 10, 2024 (GLOBE NEWSWIRE) -- The "Precision Medicine Market by Product, Technology, Application, End-user, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Global CRISPR Gene Editing Market
CRISPR Gene Editing Market Size Projected to Surpass $2 Billion by 2024 Amid Increasing Demand for Genetic Treatments - Long-term Forecast to 2028 and 2033
August 15, 2024 09:57 ET | Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Global CRISPR Gene Editing Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The CRISPR gene editing market has...
22157.jpg
Asia-Pacific Gene Editing Technology Research Report 2024
February 29, 2024 10:03 ET | Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Asia-Pacific Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The...
European Gene Editing Technologies Market
Europe's Gene Editing Technologies Market, Valued at $370 Million in 2023, is Set to Reach $3.26 Billion by 2032 - Country-Specific Insights for Agriculture & Biomedical Applications Unveiled
January 30, 2024 07:50 ET | Research and Markets
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The "Europe Gene Editing Technologies Market: Analysis and Forecast, 2023-2032" report has been added to ResearchAndMarkets.com's offering.The Europe gene...
Eric Kmiec, Ph.D., Named Editor-in-Chief of Gene and Genome Editing
September 06, 2023 13:05 ET | ChristianaCare
Wilmington, Delaware, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Eric Kmiec, Ph.D., executive director and chief scientific officer of ChristianaCare’s Gene Editing Institute, has been selected as...
ChristianaCare Spins
ChristianaCare Spins Out First Commercial Gene Editing Biotechnology Start-Up Company, CorriXR Therapeutics
October 11, 2022 08:39 ET | ChristianaCare
Wilmington, Delaware, Oct. 11, 2022 (GLOBE NEWSWIRE) -- ChristianaCare, a leading non-profit health system in the mid-Atlantic region, today announced it has spun out its first commercial...